Clinical Trial Update: Minocycline in Clinically Isolated Syndromes (CIS) [Phase 3]

View source ↗

Summary

Phase 3 trial of minocycline in Clinically Isolated Syndrome and early relapse of multiple sclerosis has completed; results are not detailed in the provided sni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Dr. Luanne Metz | Conditions: Clinically Isolated Syndromes, Early Single Relapse of Multiple Sclerosis | Phase 3 | Status: COMPLETED